The U.S. Meals and Drug Administration has authorized Dupixent (dupilumab) for the therapy of adults and adolescents with persistent spontaneous…
Read More
The U.S. Meals and Drug Administration has authorized Dupixent (dupilumab) for the therapy of adults and adolescents with persistent spontaneous…
Read MoreIn a historic announcement underscoring President Donald J. Trump’s dedication to the well being of American households, the Meals and…
Read MoreApril 22, 2025 1 min learn Add matter to e mail alerts Obtain an e mail when new articles are…
Read More